NY A00062

Prohibits prior authorization requirements for opioid medications from requiring use of non-abuse-deterrent opioids before approving abuse-deterrent opioid products.

Requires insurance carriers and health plans to cover at least one abuse-deterrent opioid analgesic drug product per active opioid ingredient on their formularies.

Limits cost-sharing for brand name abuse-deterrent opioids to not exceed the lowest cost-sharing level for brand name non-abuse-deterrent opioids under the same plan.

Limits cost-sharing for generic abuse-deterrent opioids to not exceed the lowest cost-sharing level for generic non-abuse-deterrent opioids under the same plan.

Prohibits increases in patient cost-sharing or prescriber/dispenser disincentives to achieve compliance with these coverage requirements.